Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia.
CONCLUSIONS: Based on the results, LCW is a potential pharmacological candidate for the treatment of prostatic hyperplasia.
PMID: 30724641 [PubMed - in process]
Source: Pharmaceutical Biology - Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research
More News: Benign Prostatic Hyperplasia | Biology | Drugs & Pharmacology | Hormone Replacement Therapy | Hormones | Propecia | Study